In contemporary society, there is an ongoing shift toward nighttime activities and the shortening of sleep behavior. There have also been reports of qualitative changes in labor and more people are complaining of chronic sleep disorders. The biggest problem with sleep disorders is the difficulty that sleepiness brings to daily life. While nocturnal awakening is also frequently seen to increase with age, there is no effective treatment.
This project seeks to elucidate the pathogenesis of sleep disorders that exhibit symptoms such as oversleeping and sleep fragmentation with the aim of developing new therapeutic drugs and biomarkers for use in the early diagnosis and evaluation of therapeutic efficacy.
Project Leader Taku Miyagawa